OBALON THERAPEUTICS INC·4

Jun 25, 6:56 PM ET

Hussainy Nooshin 4

4 · OBALON THERAPEUTICS INC · Filed Jun 25, 2020

Insider Transaction Report

Form 4
Period: 2020-06-23
Hussainy Nooshin
VP of Finance
Transactions
  • Award

    Stock Option

    2020-06-23+52,86552,865 total
    Exp: 2030-06-23Common Stock (52,865 underlying)
  • Award

    Stock Option (Right to Buy)

    2020-06-23+165,135165,135 total
    Exercise: $0.73Exp: 2030-06-23Common Stock (165,135 underlying)
Footnotes (2)
  • [F1]Each share of Common Stock underlying the cash-settled Option represents the right to a cash payment equal to the excess, if any, of (i) the Fair Market Value of each such share on the date of exercise over (ii) the exercise price per share set forth in the Notice of Stock Option Grant ($0.73), and such Option shall vest as to 1/36th of the shares of Common Stock underlying the Option on each monthly anniversary of the grant date, subject to the Grantee's continued service with the Company through the applicable vesting date. This Option may not be exercised for shares of the Company's Common Stock.
  • [F2]The Option shall vest as to 1/36th of the shares of Common Stock underlying the Option on each monthly anniversary of the grant date, subject to the Grantee's continued service with the Company through the applicable vesting date.

Documents

1 file
  • 4
    marketforms-49132.xmlPrimary

    PRIMARY DOCUMENT